Unlocking Potential: Biofrontera Inc. to Showcase at the ROTH Inaugural Healthcare Opportunities Conference
Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale…